 |
|
| Blog results | Results 1 - 10 of about 1,053 for raloxifene cardiovascular. (0.22 seconds) |
| Sorted by relevance Sort by date |
| 20 Nov 2009 by admin Raloxifene was found to favorably alter biochemical markers of cardiovascular risk by decreasing LOL cholesterol, fibrinogen, and lipoprotein (a), without raising trigylcerides. When compared to HRT, raloxifene had no effect on HOL ... No SubHealth - http://www.nosubhealth.com/ |
| 17 Oct 2009 by noellacwebsterf HMG-CoA amoxicillin online reductase inhibitors reduce cardiovascular mortality, although the mechanisms of action have not been completely elucidated. Overexpression of constitutively active gabapentin RhoA increased FasL expression in ... Ezetimibe Generic Dilantin Orlistat Raloxifene - http://blogs2u.org/noellacwebsterf/ |
| 24 Nov 2009 by Ani WASHINGTON - Scientists have found little evidence suggesting that menopausal women taking hormone replacement therapy are at an increased cardiovascular disease risk. ... Three drugs have been found to cut women's chances of contracting breast cancer, but each of them has distinct potential harms of its own, says a report. Issued by HHS' Agency for Healthcare Research and Quality, the report reveals that the three drugs are tamoxifen, raloxifene, and tibolone. ... Health News - http://blog.taragana.com/health/ - References [ More results from Health News ] |
| 14 Jan 2009 The trial (known as RUTH) aimed to determine whether raloxifene improved cardiovascular outcomes based on evidence from earlier studies that it improved some markers of cardiovascular risk. It involved 10101 postmenopausal women who had ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ [ More results from NeLM - News ] |
| 12 Jul 2006 (no abstract is available for this citation) New England Journal of Medicine -- Recent Issues - http://content.nejm.org/ [ More results from New England Journal of Medicine -- Recent Issues ] |
| 9 Nov 2009 by Health very improtent your life Like estrogen, tamoxifen helps increase bone density in postmenopausal women and protects the cardiovascular system. Unlike estrogen, SERMs do not promote the development of breast cells into cancer cells; however, they may increase the ... ALL ABOUT THE CANCER OF TYPES - http://canceroftypes.blogspot.com/ |
| 7 Nov 2009 by Personal Tamoxifen and raloxifene are associated with similar patterns of cognitive function in postmenopausal women at increased risk for breast cancer, indicate data from a multicenter study. Lethal prostate cancer predicted using time of PSA ... Personal Healthcare - http://personal-health-care4u.blogspot.com/ |
| 5 Apr 2007 by health blogs objective we examined whether past use of hormone therapy influences the effects of raloxifene on the risk of new vertebral fracture, cardiovascular events, or breast cancer. study design the multiple outcomes of raloxifene evaluation ... Breast Cancer - http://breastcancer-online.blogspot.com/ |
| 18 Nov 2009 by healthspanlife Tibolone, unlike appropriate HRT, has no significant reported benefit on all-cause mortality, on cardiovascular disease (which increased by 37% – p0.28), on memory/ dementia and on depression , although it almost halved fractures – but ... Healthspanlife - the Official Life! Blog - http://healthspanlife.wordpress.com/ |
| 9 Oct 2006 for every 1000 women who take raloxifene for 5 years, we can expect four to five additional strokes, six additional episodes of venous thromboembolism (vte), six fewer invasive breast cancers, and six to seven fewer clinical vertebral ... Cardiology News - http://www.mdlinx.com/InternalMDLinx/news.cfm?subspec_id=4 |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
